Long-Acting Cabotegravir/Rilpivirine Concentrations in Combination With Intravenous Rifampin: A Case Report.

Authors:
Sunagawa SW; Havens JP; Podany A; Walker B; Scarsi KK and 1 more

Journal:
Open Forum Infect Dis

Publication Year: 2023

DOI:
10.1093/ofid/ofad604

PMCID:
PMC10745268

PMID:
38143853

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Open Forum Infect Dis

Abbreviation: Open Forum Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022.
Barfield RK; Brown ML; Albrecht B and 27 more (2024) - Transparency Score: 3/6
Addressing Unmet PrEP Needs in Women: Impact of a Laboratory-Driven Protocol at an Urban, Essential…
Stewart J; Ruiz-Mercado G; Sperring H and 3 more (2024) - Transparency Score: 3/6
Adjunct Terbinafine in Patients With Leukemia and Invasive Fusariosis With Skin Lesions: Discordanc…
Matsuo T; Wurster S; Jiang Y and 2 more (2024) - Transparency Score: 3/6
Barriers to Hepatitis C Treatment and Interest in Telemedicine-Based Care Among Clients of a Syring…
Loy DE; Kamis K; Kanatser R and 1 more (2024) - Transparency Score: 2/6
Clinical Relevance of Human Immunodeficiency Virus Low-level Viremia in the Dolutegravir era: Data …
Kohler M; Brown JA; Tschumi N and 5 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Potential conflicts of interest. J.H.: investigator-initiated grant support paid to his institution from Gilead Sciences as well as participation on a scientific advisory board for ViiV Health Care. K.S.: investigator-initiated grant support paid to her institution from Organon, LLC. S.H.B.: research grants to her institution from ViiV Health Care and Janssen as well as participation on a scientific advisory board for Gilead Sciences. All the other authors report no conflicts of interest/disclosures relevant to this article."

Evidence found in paper:

"Financial support. No financial support was provided relevant to this article. Financial support ."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025